Is a prestroke modified Rankin Scale sensible?
Askiel Bruno,
Jeffrey A. Switzer,
Valerie L. Durkalski,
Fenwick T. Nichols,
Corresponding Author
Askiel Bruno
Department of Neurology, Georgia Health Sciences University
Askiel Bruno*, 1120 15th Street BI 3076, Department of Neurology, Georgia Health Sciences University, Augusta, GA 30912, USA.E-mail: [email protected]Search for more papers by this authorJeffrey A. Switzer
Department of Neurology, Georgia Health Sciences University
Search for more papers by this authorValerie L. Durkalski
Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Calrolina
Search for more papers by this authorFenwick T. Nichols
Department of Neurology, Georgia Health Sciences University
Search for more papers by this authorAskiel Bruno,
Jeffrey A. Switzer,
Valerie L. Durkalski,
Fenwick T. Nichols,
Corresponding Author
Askiel Bruno
Department of Neurology, Georgia Health Sciences University
Askiel Bruno*, 1120 15th Street BI 3076, Department of Neurology, Georgia Health Sciences University, Augusta, GA 30912, USA.E-mail: [email protected]Search for more papers by this authorJeffrey A. Switzer
Department of Neurology, Georgia Health Sciences University
Search for more papers by this authorValerie L. Durkalski
Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Calrolina
Search for more papers by this authorFenwick T. Nichols
Department of Neurology, Georgia Health Sciences University
Search for more papers by this authorConflict of interest: None declared.
No abstract is available for this article.
References
- 1 van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–7.
- 2 Ogawa A, Mori E for the MELT Japan Study Group. et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633–9.
- 3 Mayer SA, Brun NC, Begtrup K. et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358: 2127–37.
- 4 Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141–50.
- 5 Levy DE, del Zoppo GJ, Demaerschalk BM et al. Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program. Stroke 2009; 40: 3796–803.
- 6 Potter JF, Robinson TG, Ford GA et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurology 2009; 8: 48–56.
- 7 Meurer WJ, Scott PA, Caveney AF et al. Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke 2010; 5: 163–6.
- 8 Modified Rankin scale, English.. Available at http://trials-rankin.Trainingcampus.Net/uas/modules/trees/windex.Aspx (accessed March 29, 2011).
- 9 Wilson L. Structured interview for the modified Rankin scale: questionnaire and guidelines. Available at http://www.Psychology.Stir.Ac.Uk/staff/lwilson/documents/mrs_structured_interview.Pdf (accessed March 29, 2011).
- 10 Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, Bone I. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke 2002; 33: 2243–6.
- 11 The Barthel Index of activities of daily living.. Available at http://www.healthcare.uiowa.edu/igec/tools/function/barthelADLs.pdf (accessed March 29, 2011).
Citing Literature
